Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Blood pressure | D001794 | EFO_0004325 | — | — | — | — | 1 | — | 1 |
Platelet activation | D015539 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Syndrome | D013577 | — | — | 1 | 3 | 1 | — | — | 4 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 3 | 1 | — | 1 | 4 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 3 | 1 | — | 1 | 4 |
Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | — | 2 | 1 | — | — | 3 |
Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | — | — | 1 | — | 1 | 2 |
Thrombocytopenia | D013921 | HP_0001873 | D69.6 | 1 | 1 | 1 | — | — | 2 |
Thrombocytopenic purpura | D011696 | — | — | — | — | 1 | — | 1 | 2 |
Purpura | D011693 | HP_0000979 | D69.2 | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 20 | 3 | — | — | — | 21 |
Melanoma | D008545 | — | — | 14 | 9 | — | — | — | 18 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 12 | 3 | — | — | — | 12 |
Carcinoma | D002277 | — | C80.0 | 10 | 4 | — | — | — | 12 |
Lymphoma | D008223 | — | C85.9 | 9 | 3 | — | — | — | 11 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 8 | 3 | — | — | — | 10 |
Adenocarcinoma | D000230 | — | — | 6 | 6 | — | — | — | 8 |
Non-small-cell lung carcinoma | D002289 | — | — | 7 | 3 | — | — | — | 8 |
Leukemia | D007938 | — | C95 | 8 | 1 | — | — | — | 8 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 7 | 1 | — | — | — | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
B-cell lymphoma | D016393 | — | — | 5 | — | — | — | — | 5 |
Multiple myeloma | D009101 | — | C90.0 | 4 | — | — | — | — | 4 |
Plasma cell neoplasms | D054219 | — | — | 4 | — | — | — | — | 4 |
Glandular and epithelial neoplasms | D009375 | — | — | 4 | — | — | — | — | 4 |
Follicular lymphoma | D008224 | — | C82 | 3 | — | — | — | — | 3 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 3 | — | — | — | — | 3 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | — | — | — | — | 2 |
Merkel cell carcinoma | D015266 | EFO_1001471 | C4A | 2 | — | — | — | — | 2 |
Glioma | D005910 | EFO_0000520 | — | 2 | — | — | — | — | 2 |
Myoepithelioma | D009208 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Primary immunodeficiency diseases | D000081207 | — | — | — | — | — | — | 2 | 2 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 1 | 1 |
Humoral immunity | D056724 | — | — | — | — | — | — | 1 | 1 |
Coronary disease | D003327 | — | — | — | — | — | — | 1 | 1 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | — | — | 1 | 1 |
Coronary artery disease | D003324 | — | I25.1 | — | — | — | — | 1 | 1 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | — | 1 | 1 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
Atherosclerotic plaque | D058226 | HP_0031678 | I70 | — | — | — | — | 1 | 1 |
Septic shock | D012772 | — | A48.3 | — | — | — | — | 1 | 1 |
Drug common name | Selicrelumab |
INN | selicrelumab |
Description | CP-870893 (mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109477 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 0O39RGI33V (ChemIDplus, GSRS) |